Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era

ObjectiveHuman identical sequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) promoted the coronavirus disease 2019 (COVID-19) progression by upregulating hyaluronic acid (HA) via NamiRNA-enhancer network, based on previous experimental research. This study aimed to investigate...

Full description

Bibliographic Details
Main Authors: Yanyan Li, Xinyu Cui, Na Zhu, Yingying Lin, Xin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1338508/full
_version_ 1797320879319810048
author Yanyan Li
Xinyu Cui
Na Zhu
Yingying Lin
Xin Li
author_facet Yanyan Li
Xinyu Cui
Na Zhu
Yingying Lin
Xin Li
author_sort Yanyan Li
collection DOAJ
description ObjectiveHuman identical sequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) promoted the coronavirus disease 2019 (COVID-19) progression by upregulating hyaluronic acid (HA) via NamiRNA-enhancer network, based on previous experimental research. This study aimed to investigate the predictive value of HA for the severity of SARS-CoV-2 infection in the post-COVID-19 era.MethodsA total of 217 consecutive patients with COVID-19 were enrolled at Beijing Ditan Hospital between July 2023 and October 2023. HA levels were analyzed using biochemical detector. Logistic regression analysis was used to screen independent factors for severe COVID-19. The predictive performance of HA for severe infection was assessed by ROC curve. Furthermore, the relationship between HA levels and COVID-19 severity was investigated using multivariate logistic regression models after adjustment for potential confounders.ResultsAccording to the cut-off value of HA, COVID-19 patients were divided into HA < 90 ng/mL group (80 cases) and HA ≥ 90 ng/mL group (137 cases). High HA levels were positively associated with the severe SARS-CoV-2 infection, including elevated inflammatory indicators, severe lung involvement, prolonged clinical course, and higher incidence of respiratory failure and death (P < 0.05). Logistic regression analysis suggested that HA was an independent predictor of severe COVID-19 (OR = 4.540, 95% CI = 2.105-9.790, P < 0.001). ROC curve analysis showed that the AUC of HA for severe infection was 0.724. HA levels were significantly higher in COVID-19 cases compared to the healthy population (123.9 (82.6, 174.1) vs. 50.5 (37.8, 66.8), P < 0.001), but similar to those with non-SARS-CoV-2 lung infection (121.6 (78.5, 175.6) vs. 106.0 (66.5, 149.7), P = 0.244). We also found that the first COVID-19 infections had higher HA levels (118.8 (79.5, 174.3) vs. 85.0 (61.1, 128.8), P < 0.001) and a higher proportion of severe infection (37.1% vs. 21.3%, P = 0.043) than re-infections. However, HA expression failed to fully return to normal levels with infection recovery (204.7 (152.9, 242.2) vs. 97.0 (69.3, 137.3), P < 0.001).ConclusionHA was associated with severe SARS-CoV-2 infection and could be used as a novel serum biomarker to predict the risk of COVID-19 progression in the post-COVID-19 era.
first_indexed 2024-03-08T04:49:23Z
format Article
id doaj.art-26d739ad416f4e80b359cf73c77bf2b8
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-03-08T04:49:23Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-26d739ad416f4e80b359cf73c77bf2b82024-02-08T05:16:17ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-02-011410.3389/fcimb.2024.13385081338508Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 eraYanyan Li0Xinyu Cui1Na Zhu2Yingying Lin3Xin Li4Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaCenter of Integrative Medicine, Peking University Ditan Teaching Hospital, Beijing, ChinaCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, ChinaObjectiveHuman identical sequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) promoted the coronavirus disease 2019 (COVID-19) progression by upregulating hyaluronic acid (HA) via NamiRNA-enhancer network, based on previous experimental research. This study aimed to investigate the predictive value of HA for the severity of SARS-CoV-2 infection in the post-COVID-19 era.MethodsA total of 217 consecutive patients with COVID-19 were enrolled at Beijing Ditan Hospital between July 2023 and October 2023. HA levels were analyzed using biochemical detector. Logistic regression analysis was used to screen independent factors for severe COVID-19. The predictive performance of HA for severe infection was assessed by ROC curve. Furthermore, the relationship between HA levels and COVID-19 severity was investigated using multivariate logistic regression models after adjustment for potential confounders.ResultsAccording to the cut-off value of HA, COVID-19 patients were divided into HA < 90 ng/mL group (80 cases) and HA ≥ 90 ng/mL group (137 cases). High HA levels were positively associated with the severe SARS-CoV-2 infection, including elevated inflammatory indicators, severe lung involvement, prolonged clinical course, and higher incidence of respiratory failure and death (P < 0.05). Logistic regression analysis suggested that HA was an independent predictor of severe COVID-19 (OR = 4.540, 95% CI = 2.105-9.790, P < 0.001). ROC curve analysis showed that the AUC of HA for severe infection was 0.724. HA levels were significantly higher in COVID-19 cases compared to the healthy population (123.9 (82.6, 174.1) vs. 50.5 (37.8, 66.8), P < 0.001), but similar to those with non-SARS-CoV-2 lung infection (121.6 (78.5, 175.6) vs. 106.0 (66.5, 149.7), P = 0.244). We also found that the first COVID-19 infections had higher HA levels (118.8 (79.5, 174.3) vs. 85.0 (61.1, 128.8), P < 0.001) and a higher proportion of severe infection (37.1% vs. 21.3%, P = 0.043) than re-infections. However, HA expression failed to fully return to normal levels with infection recovery (204.7 (152.9, 242.2) vs. 97.0 (69.3, 137.3), P < 0.001).ConclusionHA was associated with severe SARS-CoV-2 infection and could be used as a novel serum biomarker to predict the risk of COVID-19 progression in the post-COVID-19 era.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1338508/fullhyaluronic acidsevere acute respiratory syndrome coronavirus-2coronavirus disease 2019severe infectionlung involvementprogression
spellingShingle Yanyan Li
Xinyu Cui
Na Zhu
Yingying Lin
Xin Li
Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
Frontiers in Cellular and Infection Microbiology
hyaluronic acid
severe acute respiratory syndrome coronavirus-2
coronavirus disease 2019
severe infection
lung involvement
progression
title Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
title_full Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
title_fullStr Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
title_full_unstemmed Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
title_short Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era
title_sort elevated hyaluronic acid levels in severe sars cov 2 infection in the post covid 19 era
topic hyaluronic acid
severe acute respiratory syndrome coronavirus-2
coronavirus disease 2019
severe infection
lung involvement
progression
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1338508/full
work_keys_str_mv AT yanyanli elevatedhyaluronicacidlevelsinseveresarscov2infectioninthepostcovid19era
AT xinyucui elevatedhyaluronicacidlevelsinseveresarscov2infectioninthepostcovid19era
AT nazhu elevatedhyaluronicacidlevelsinseveresarscov2infectioninthepostcovid19era
AT yingyinglin elevatedhyaluronicacidlevelsinseveresarscov2infectioninthepostcovid19era
AT xinli elevatedhyaluronicacidlevelsinseveresarscov2infectioninthepostcovid19era